BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33916308)

  • 1. The Mink Circovirus Capsid Subunit Expressed by Recombinant Baculovirus Protects Minks against Refractory Diarrhea in Field.
    Wang L; Zhang Y; Chen T; Mi L; Sun X; Zhou X; Miao F; Zhang S; Liu Y; Hu R
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of an indirect enzyme-linked immunosorbent assay based on recombinant capsid protein for the detection of mink circovirus infection.
    Ge J; Cui X; Shi Y; Zhao L; Wei C; Wen S; Xia S; Chen H
    BMC Vet Res; 2018 Jan; 14(1):29. PubMed ID: 29373971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2.
    Ye Y; Cheng X; Zhang J; Tong T; Lin W; Liao M; Fan H
    Virol J; 2013 Oct; 10():316. PubMed ID: 24161107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of pigeon circovirus-like particles using baculovirus expression system.
    Gai W; Zheng W; Zhao Z; Wong G; Sun P; Yan L; He H; Zheng X
    Microb Pathog; 2020 Feb; 139():103905. PubMed ID: 31790792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of recombinant beak and feather disease virus capsid protein as a vaccine for psittacine beak and feather disease.
    Bonne N; Shearer P; Sharp M; Clark P; Raidal S
    J Gen Virol; 2009 Mar; 90(Pt 3):640-647. PubMed ID: 19218209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
    Jung BK; Kim HR; Lee YH; Jang H; Chang KS
    J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
    He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
    Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
    Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
    Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral application of freeze-dried yeast particles expressing the PCV2b Cap protein on their surface induce protection to subsequent PCV2b challenge in vivo.
    Patterson R; Eley T; Browne C; Martineau HM; Werling D
    Vaccine; 2015 Nov; 33(46):6199-205. PubMed ID: 26476879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.
    Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S
    J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baculovirus as a PRRSV and PCV2 bivalent vaccine vector: baculovirus virions displaying simultaneously GP5 glycoprotein of PRRSV and capsid protein of PCV2.
    Xu XG; Wang ZS; Zhang Q; Li ZC; Ding L; Li W; Wu HY; Chang CD; Lee LH; Tong DW; Liu HJ
    J Virol Methods; 2012 Feb; 179(2):359-66. PubMed ID: 22172969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of circoviruses associated with acute gastroenteritis in minks in northeastern China.
    Ge J; Gu S; Cui X; Zhao L; Ma D; Shi Y; Wang Y; Lu T; Chen H
    Arch Virol; 2018 Oct; 163(10):2727-2735. PubMed ID: 29948383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
    Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
    BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
    Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
    Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.